The increasing interest in effective weight management has led to considerable investigation into groundbreaking treatments. Lately , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has exhibited encouraging results in clinical trials, indicating potential for substantial weight decrease. Therefore, many indi